GBSN
Seite 1 von 43 Neuester Beitrag: 15.07.17 07:42 | ||||
Eröffnet am: | 19.09.16 19:11 | von: Gerd Geldha. | Anzahl Beiträge: | 2.061 |
Neuester Beitrag: | 15.07.17 07:42 | von: CentTrader | Leser gesamt: | 106.971 |
Forum: | Börse | Leser heute: | 20 | |
Bewertet mit: | ||||
Seite: < 1 | 2 | 3 | 4 | 41 | 42 | 43 43 > |
Angebliches PriceTarget 1$ innerhalb 12 Monaten
Quelle direkt:
http://irdirect.net/prviewer/release/id/2577843
Stammt von hier:
http://www.seethruequity.com/news/
Ob die das ernst meinen?
posted on July 5, 2017 in Featured, In the News, Investors
On July 5, 2017, Seethru Equity issued a press release regarding an update to their 2015 research report on Great Basin. The press release discusses the Company’s expanded menu, growing sales funnel, and sets a new price target."
http://gbscience.com/seethru-equity-issues-update-report-gbsn/
Investor Presentation
posted on July 7, 2017 in Featured, Investors
GBSN Investor Deck – July 2017_FINAL
http://gbscience.com/wp-content/uploads/...eck-July-2017_FINAL-1.pptx
Hier der PDF-Link für die heutige Präsentation:
http://gbscience.com/wp-content/uploads/...r-Deck-July-2017_FINAL.pdf
Ist jetzt auch so auf der Website aufrufbar.
▪ Common shares & equivalents outstanding–11.6MM (incl. shares from Series K Warrants)
▪ No variable priced instruments
▪ $20.3 million Series A Convertible Note
▪ Convertible at $3.00 a share, no resets or variable rate conversions, 6.8 million shares
▪ Not convertible for 6 months from issuance (April 17, 2017)
▪ Other debt of $1.8MM, including $0.1MM Series B Convertible Note, convertible at $1.10
▪ Enterprise value of approximately $26.7MM
▪ Series J warrants are exercisable into 22.4MM shares until August 21, 2017
▪ Exercise price of $0.30 (subject to adjustment by the Company)
Artikel:
http://www.finanznachrichten.de/...gangenheit-gesunde-zukunft-620.htm
http://globenewswire.com/news-release/2017/07/13/...hogens-Panel.html
"...As announced in the Company’s Business Update on June 26, 2017, the Company had approximately $5.0 million of potential new revenues in the new business pipeline, of which SBPP comprises nearly $2.0 million. These potential revenue estimates, as well as those below are based on the evaluating site’s own estimate of their expected testing volumes multiplied by the product price offered to the prospective customer. ..."
Weiterlesen im Thread
http://www.ariva.de/forum/...kaufkurse-547917?new_pnr=23017013#bottom
Beitrag #6
Hab mich schon gewundert, daß hier außer mir keiner gepostet hat. Hab hier aus alter Gewohnheit weitergeschrieben, ohne den neuen Thread zu bemerken.